Madrigal Pharmaceuticals, Inc. (MDGL)

434.80 +8.95 (+2.10%) USD  |  NASDAQ  |  Mar 04, 16:00
435.00 +0.20 (+0.05%) Pre-Market: 08:10
More

Madrigal Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
Johnson & Johnson Upgrade